Drawing based on the label description. No photo yet.
“The capsules are axially printed with MYLAN over SM 25 in black ink on cap and body. The 37.5 mg capsules are hard-shell gelatin capsules with an ivory opaque cap and ivory opaque body filled with yellow to orange powder”
MYLAN SM 25 pill
Pill with imprint MYLAN SM 25 is pink & yellow, capsule, 18 mm and has been identified as Sunitinib Malate 25 mg. It is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors. It is supplied by Mylan Pharmaceuticals Inc.
Sunitinib Malate 25 mg
- Imprint
- MYLAN SM 25
- Strength
- 25 mg
- Used for
- Renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors
- Color
- Pink, Yellow
- Shape
- Capsule / oblong
- Size
- 18 mm
- Score
- No score line
- Form
- Capsule
- Manufacturer
- Mylan Pharmaceuticals Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- NDC
- 0378-6679, 0378-6679-28
Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .
Report a mistake
What is Sunitinib Malate used for?
Sunitinib Malate is used for renal cell carcinoma, pancreatic neoplasms and neuroendocrine tumors.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Gastrointestinal Stromal Tumor
Sunitinib malate capsules are indicated for the treatment of adult patients with gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate.
Advanced Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the treatment of adult patients with advanced renal cell carcinoma (RCC).
Adjuvant Treatment of Renal Cell Carcinoma
Sunitinib malate capsules are indicated for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy.
Advanced Pancreatic Neuroendocrine Tumors
Sunitinib malate capsules are indicated for the treatment of progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in adult patients with unresectable locally advanced or metastatic disease.
From the FDA-approved label on DailyMed (published Sep 02, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your pill? Check every detail
- Your pill shows MYLAN SM 25. The parts can be split between the two sides, so turn the pill over and check both.
- It is pink & yellow, capsule, 18 mm.
- Its score line and coating match the details on this page.
- It came from a pharmacy package that names the same drug.
Ingredients
Active: Sunitinib Malate
Inactive: Silicon Dioxide, Croscarmellose Sodium, Gelatin, Unspecified, Magnesium Stearate, Mannitol, Sodium Lauryl Sulfate, Titanium Dioxide, Ferric Oxide Red, Ferric Oxide Yellow, Ammonia, Ferrosoferric Oxide, Propylene Glycol, Shellac
Pills that look similar but are different drugs
Same color and shape, different medicine. This is why the imprint matters.
-
724 par
Hydroxyurea 500 mg
Green & pink, capsule, 19 mm
Used for psoriasis and prostate cancer
-
AMNEAL 584
Temazepam 22.5 mg
Pink & white, capsule, 18 mm
Used for depression and panic disorder
Schedule IV
-
Y 562
Diltiazem Hydrochloride 120 mg
Pink, capsule, 19 mm
Used for high blood pressure and atrial fibrillation (irregular heartbeat)
-
Y 688
Diltiazem Hydrochloride 90 mg
Pink & yellow, capsule, 18 mm
Used for high blood pressure and atrial fibrillation (irregular heartbeat)
-
G 585
Aprepitant 125 mg
Pink & white, capsule, 19 mm
Used for nausea and vomiting
-
AMNEAL 803
Temozolomide 100 mg
Pink & white, capsule, 19 mm
Used for glioblastoma and melanoma
Other Sunitinib Malate pills
- SC 12 5 Sunitinib Malate 12.5 mg Gray, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- MYLAN SM 12 5 Sunitinib Malate 12.5 mg Pink, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- STN 12 5 Sunitinib Malate 12.5 mg Yellow, capsule, 11 mm Used for renal cell carcinoma and pancreatic neoplasms
- RM53 RM53 Sunitinib Malate 12.5 mg Brown, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- S12 5 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- 6 MS Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- TEVA 8199 TEVA 8199 Sunitinib Malate 12.5 mg Red, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms
- Pfizer STN 12 5 mg Sunitinib Malate 12.5 mg Orange, capsule, 14 mm Used for renal cell carcinoma and pancreatic neoplasms